Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
368 studies found for:    "mycosis fungoides"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed
Has Results
Safety and Efficacy of Nitrogen Mustard in Treatment of Mycosis Fungoides
Condition: Mycosis Fungoides
Intervention: Drug: mechlorethamine-MCH (nitrogen mustard)
2 Terminated Study of Low-Dose Total Skin Electron Beam Therapy in Mycosis Fungoides
Condition: Mycosis Fungoides
Intervention: Device: Low-dose total skin electron beam therapy (4 Gy)
3 Not yet recruiting Safety and Effectiveness of A-dmDT390-bisFv(UCHT1) Fusion Protein in Subjects With Mycosis Fungoides
Condition: Mycosis Fungoides
Interventions: Biological: A-dmDT390-bisFv(UCHT1);   Drug: Vorinostat
4 Withdrawn Phase I/II Study of Intratumoral Injection of CPG 7909, a TLR9 Agonist, Combined With Local Radiation for Patients With Recurrent Mycosis Fungoides.
Condition: Mycosis Fungoides
Intervention: Drug: CPG 7909
5 Completed An Open Label Study to Evaluate the Safety and Efficacy of Mechlorethamine(MCH) 0.04% Formulation in Mycosis Fungoides
Condition: Mycosis Fungoides
Intervention: Drug: 0.04% Mechlorethamine gel
6 Recruiting PUVA Maintenance Therapy in Mycosis Fungoides
Condition: Patch/Plaque Stage Mycosis Fungoides
Intervention: Drug: 8-methoxypsoralen
7 Recruiting Clinical Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell Lymphoma
Condition: Mycosis Fungoides
Intervention: Drug: Valchlor
8 Unknown  Study of Alemtuzumab to Treat Advanced Mycosis Fungoides/Sezary Syndrome
Conditions: Mycosis Fungoides;   Sezary Syndrome
Intervention: Drug: alemtuzumab
9 Terminated Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome
Conditions: Mycosis Fungoides;   Sezary Syndrome
Intervention: Drug: HuMax-CD4 (zanolimumab)
10 Terminated PUVA Versus PUVA + IFN Alpha 2a in Mycosis Fungoides
Condition: Cutaneous T-Cell Lymphoma (Mycosis Fungoides)
Interventions: Drug: PUVA (8MOP + UVA) + IFN;   Drug: PUVA (8-MOP + UVA)
11 Recruiting Stem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis Fungoides and Sezary Syndrome
Conditions: Mycosis Fungoides;   Sezary Syndrome
Intervention: Drug: Campath-1H
12 Not yet recruiting TSEB and Brentuximab for Treatment of Mycosis Fungoides & Sezary Syndrome
Conditions: Mycosis Fungoides;   Sézary Syndrome
Interventions: Radiation: TSEB Therapy;   Drug: Brentuximab vedotin
13 Not yet recruiting Low Dose Total Skin Electron Beam Treatment (TSEBT) Followed by Maintenance Valchlor for Patients With Mycosis Fungoides
Conditions: Mycosis Fungoides;   Cutaneous T-cell Lymphoma
Interventions: Radiation: Total skin electron beam therapy (TSEBT);   Drug: mechlorethamine gel 0.016%
14 Completed Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2A
Conditions: Cutaneous T Cell Lymphoma;   Mycosis Fungoides
Intervention: Drug: Methoxsalen+ECP
15 Not yet recruiting ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
Conditions: Mycosis Fungoides;   Non-Hodgkin's Lymphoma
Intervention:
16 Recruiting Low-Dose Total Skin Electron Therapy in Treating Patients With Refractory or Relapsed Stage IB-IIIA Mycosis Fungoides
Conditions: Recurrent Mycosis Fungoides;   Refractory Mycosis Fungoides;   Stage I Mycosis Fungoides;   Stage II Mycosis Fungoides;   Stage III Mycosis Fungoides
Interventions: Other: Quality-of-Life Assessment;   Other: Objective Grading of Skin Findings
17 Unknown  Multicentre Phase I Trial of Engineered T Cells for Patients With Relapsed or Refractory Primary Cutaneous CD30+ Large T Cell Lymphoma or Transformed CD30+ Mycosis Fungoides
Conditions: CD30 Positive Cutaneous T Cell Lymphoma;   CD30 Positive Transformed Mycosis Fungoides
Intervention: Genetic: Genetically modified T cells # 1138
18 Recruiting Resminostat for Maintenance Treatment of Patients With Advanced Stage Mycosis Fungoides (MF) or Sézary Syndrome (SS)
Conditions: Mycosis Fungoides;   Sezary Syndrome;   Lymphoma, T-Cell, Cutaneous
Interventions: Drug: resminostat;   Drug: Placebo
19 Terminated Phase II Total Skin Electron Beam Therapy (TSEBT 12 Gy) in Stage IB-IIIA Mycosis Fungoides
Conditions: Mycosis Fungoides;   Lymphomas: Non-Hodgkin;   Lymphomas: Non-Hodgkin Peripheral T-Cell;   Lymphomas: Non-Hodgkin Cutaneous Lymphoma
Intervention: Device: Total Skin Electron Beam Therapy (TSEBT)
20 Recruiting Safety, Tolerability and Pharmacokinetic Study of MRG-106 in Patients With Cutaneous T Cell Lymphoma (CTCL), MF Subtype
Conditions: Cutaneous T-cell Lymphoma (CTCL);   Mycosis Fungoides
Intervention: Drug: MRG-106

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.